Health ❯ Nutrition ❯ Weight Management ❯ Pharmaceuticals
NIH-funded research shows a modest reduction in obesity-related cancer risk and all-cause mortality among diabetic adults using GLP-1 receptor agonists, with notable benefits for women.
